Replies to post #11730 on DNAprint Genomics (DNAG)

[mingwan0]

So why did Bayer and AstraZeneca partner with Genaissance in 2003 in relation to STRENGTH? I agree with the deficiency of the program but it is not dead in the water yet, and Genaissance are still updating their patents. I have spent a lot of time reviewing all the statin response patents (not just DNAP and GNSC) and will post something about the relative merits of each when I get a chance.